Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.256, 2000-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Debating RSV prophylaxis in preterm infants
Inpharma, Vol. 1, Iss. 1266, 2000-01 ,pp. :
Debating RSV prophylaxis in preterm infants
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 291, 2000-01 ,pp. :
Preventing RSV infection in infants remains a dream
Inpharma, Vol. 1, Iss. 1436, 2004-01 ,pp. :
Burden of RSV infections in infants leaves parents gasping
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 412, 2003-01 ,pp. :
Palivizumab for RSV prevention in high-risk children
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 520, 2007-01 ,pp. :